Yearly Publication Trends - Vaccine

Year	Publication Count
2024	8713
2023	32192
2022	23439
2021	16570
2020	9465
2019	5813
2018	3903
2017	3882
2016	3929
2015	3511
2014	4019

Relevant Publications

Partnering to Address Health Inequities among Incarcerated Populations: Prisons, Jails, and COVID-19 Vaccination.

Issue Release: 2024

Incidence and prevalence of hepatitis C and B infections among men who have sex with men and transgender women enrolled in a United States HIV vaccine trial.

Issue Release: 2024

Incorporating Queueing Theory into a Spatial Optimization Framework to Improve Mass Vaccination Programs.

Issue Release: 2024

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study.

Issue Release: 2024

Highlight of 2023: Advances in germinal centers.

Issue Release: 2024

Sustained release of inactivated H1N1 virus from degradable microparticles for extended vaccination.

Issue Release: 2024

Expectations Versus Fantasies and Vaccine Hesitancy: How Suffering From COVID-19 Versus Suffering From Vaccines Interact.

Issue Release: 2024

Mammalian Meat Allergy and IgE to Alpha-gal in in Central Virginia: findings from a COVID-19 vaccine and patient cohort.

Issue Release: 2024

[Actual Access and Usage of Antipyretic Analgesics before and after COVID-19 Vaccination: Pharmacist\'s Roles in Promoting Proper Use of Medicines during the Infodemic].

Issue Release: 2024

Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1).

Issue Release: 2024

Rapid Development of a Registry to Accelerate COVID-19 Vaccine Clinical Trials.

Issue Release: 2024

Knowledge About Cervical Cancer and Awareness About Human Papillomavirus Vaccination Among Medical Students at the Northern Border University, Arar, Kingdom of Saudi Arabia.

Issue Release: 2024

piSTING: A Pocket-Independent Agonist Based on Multivalency-Driven STING Oligomerization.

Issue Release: 2024

Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy.

Issue Release: 2024

SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

Issue Release: 2024

An educational approach to develop intercultural nursing care for refugees from Ukraine: A qualitative study.

Issue Release: 2024

Evolution of Pyrrolysyl-tRNA Synthetase: From Methanogenesis to Genetic Code Expansion.

Issue Release: 2024

Profile and Geospatial Analysis of Dog Bite Cases Attending the Antirabies Vaccine Outpatient Department at the Tertiary Level Hospital of Mumbai.

Issue Release: 2024

Perception and Acceptance of the Newly Introduced COVID-19 Precaution (THIRD) Vaccination Dose among Health Workers at an Indian Medical College.

Issue Release: 2024

COVID-19 Vaccine Acceptance in the Sub-Himalayan Region.

Issue Release: 2024

What Are the Benefits of Vaccination Despite These Risks?

What is CRISPR?

What happens if a safety issue is identified after a vaccine is approved?

How is Vaccine Reporting Conducted?

Are There Any Special Recommendations?

What are Experimental Vaccines?

How Can Technology Facilitate Community Engagement?

What is a Vaccine?

What is Vaccine Access?

Which Vaccines Are More Likely to Cause Pain?

Partnered Content Networks

Relevant Topics